Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial (Q69803497)
Jump to navigation
Jump to search
scientific article published on 01 November 1989
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial |
scientific article published on 01 November 1989 |
Statements
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial (English)
M O Gordon
M R Hoff
J M Parkinson
W M Hart